問卷

TPIDB > Principal Investigator

Principal Investigator


Hualien Tzu Chi Hospital

Division of Nephrology

更新時間:2024-02-21

郭秋煌
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2023-12-28 - 2027-02-28

Phase III

A Phase III, Randomized, Investigator-Blinded, Active-Controlled Study of Efficacy and Safety of Efepoetin Alfa for Treatment of Anemia in Patients with Chronic Kidney Disease on Dialysis
  • Condition/Disease

    Chronic Kidney Disease on Dialysis

  • Test Drug

    Efepoetin alfa (GX-E4)

Participate Sites
5Sites

Recruiting5Sites